612 related articles for article (PubMed ID: 19245435)
1. Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells.
Kobune M; Takimoto R; Murase K; Iyama S; Sato T; Kikuchi S; Kawano Y; Miyanishi K; Sato Y; Niitsu Y; Kato J
Cancer Sci; 2009 May; 100(5):948-55. PubMed ID: 19245435
[TBL] [Abstract][Full Text] [Related]
2. Role of hedgehog signaling in ovarian cancer.
Bhattacharya R; Kwon J; Ali B; Wang E; Patra S; Shridhar V; Mukherjee P
Clin Cancer Res; 2008 Dec; 14(23):7659-66. PubMed ID: 19047091
[TBL] [Abstract][Full Text] [Related]
3. Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer.
Fukaya M; Isohata N; Ohta H; Aoyagi K; Ochiya T; Saeki N; Yanagihara K; Nakanishi Y; Taniguchi H; Sakamoto H; Shimoda T; Nimura Y; Yoshida T; Sasaki H
Gastroenterology; 2006 Jul; 131(1):14-29. PubMed ID: 16831586
[TBL] [Abstract][Full Text] [Related]
4. Gli2 expression and human bladder transitional carcinoma cell invasiveness.
Mechlin CW; Tanner MJ; Chen M; Buttyan R; Levin RM; Mian BM
J Urol; 2010 Jul; 184(1):344-51. PubMed ID: 20488474
[TBL] [Abstract][Full Text] [Related]
5. The hedgehog signaling pathway in the mouse ovary.
Russell MC; Cowan RG; Harman RM; Walker AL; Quirk SM
Biol Reprod; 2007 Aug; 77(2):226-36. PubMed ID: 17392501
[TBL] [Abstract][Full Text] [Related]
6. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
Xu FG; Ma QY; Wang Z
Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells.
Elamin MH; Shinwari Z; Hendrayani SF; Al-Hindi H; Al-Shail E; Khafaga Y; Al-Kofide A; Aboussekhra A
Mol Carcinog; 2010 Mar; 49(3):302-14. PubMed ID: 20025076
[TBL] [Abstract][Full Text] [Related]
8. Cyclopamine induces eosinophilic differentiation and upregulates CD44 expression in myeloid leukemia cells.
Takahashi T; Kawakami K; Mishima S; Akimoto M; Takenaga K; Suzumiya J; Honma Y
Leuk Res; 2011 May; 35(5):638-45. PubMed ID: 20971508
[TBL] [Abstract][Full Text] [Related]
9. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells.
Elmaagacli AH; Koldehoff M; Peceny R; Klein-Hitpass L; Ottinger H; Beelen DW; Opalka B
Haematologica; 2005 Mar; 90(3):326-34. PubMed ID: 15749664
[TBL] [Abstract][Full Text] [Related]
10. In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice.
Sanchez P; Ruiz i Altaba A
Mech Dev; 2005 Feb; 122(2):223-30. PubMed ID: 15652709
[TBL] [Abstract][Full Text] [Related]
11. Modulators of the hedgehog signaling pathway.
Heretsch P; Tzagkaroulaki L; Giannis A
Bioorg Med Chem; 2010 Sep; 18(18):6613-24. PubMed ID: 20708941
[TBL] [Abstract][Full Text] [Related]
12. Activation of hedgehog signaling inhibits osteoblast differentiation of human mesenchymal stem cells.
Plaisant M; Fontaine C; Cousin W; Rochet N; Dani C; Peraldi P
Stem Cells; 2009 Mar; 27(3):703-13. PubMed ID: 19096040
[TBL] [Abstract][Full Text] [Related]
13. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
[TBL] [Abstract][Full Text] [Related]
14. The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype.
Colado E; Alvarez-Fernández S; Maiso P; Martín-Sánchez J; Vidriales MB; Garayoa M; Ocio EM; Montero JC; Pandiella A; San Miguel JF
Haematologica; 2008 Jan; 93(1):57-66. PubMed ID: 18166786
[TBL] [Abstract][Full Text] [Related]
15. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
Levitt RJ; Zhao Y; Blouin MJ; Pollak M
Cancer Lett; 2007 Oct; 255(2):300-6. PubMed ID: 17602833
[TBL] [Abstract][Full Text] [Related]
16. Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response.
Sims-Mourtada J; Izzo JG; Apisarnthanarax S; Wu TT; Malhotra U; Luthra R; Liao Z; Komaki R; van der Kogel A; Ajani J; Chao KS
Clin Cancer Res; 2006 Nov; 12(21):6565-72. PubMed ID: 17085672
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor and hedgehog signaling pathways are active in esophageal cancer cells from rat reflux model.
Sui G; Bonde P; Dhara S; Broor A; Wang J; Marti G; Feldmann G; Duncan M; Montgomery E; Maitra A; Harmon JW
J Surg Res; 2006 Jul; 134(1):1-9. PubMed ID: 16488438
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin B is a target of Hedgehog signaling in pancreatic cancer.
Hwang JH; Lee SH; Lee KH; Lee KY; Kim H; Ryu JK; Yoon YB; Kim YT
Cancer Lett; 2009 Jan; 273(2):266-72. PubMed ID: 19004543
[TBL] [Abstract][Full Text] [Related]
19. Hedgehog signaling and cell cycle control in differentiating erythroid progenitors.
Detmer K; Thompson AJ; Garner RE; Walker AN; Gaffield W; Dannawi H
Blood Cells Mol Dis; 2005; 34(1):60-70. PubMed ID: 15607701
[TBL] [Abstract][Full Text] [Related]
20. Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway.
Bortul R; Tazzari PL; Billi AM; Tabellini G; Mantovani I; Cappellini A; Grafone T; Martinelli G; Conte R; Martelli AM
Br J Haematol; 2005 Jun; 129(5):677-86. PubMed ID: 15916691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
